[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Brawn Pharmaceuticals Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Brawn Pharmaceuticals Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Bristol-Myers Squibb Company - Business Profile with Financial and SWOT Analysis

US$ 200.00

Bristol-Myers Squibb Company - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Bruker Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Bruker Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

BTG plc - Business Profile with Financial and SWOT Analysis

US$ 200.00

BTG plc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Bukwang pharm. co., Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Bukwang pharm. co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Burcon Nutrascience Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Burcon Nutrascience Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

C & O Pharmaceutical Technology Holdings Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

C & O Pharmaceutical Technology Holdings Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cadence Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cadence Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cadila Healthcare Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cadila Healthcare Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cadus Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cadus Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cairo Pharmaceuticals & Chemical Industries Co. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cairo Pharmaceuticals & Chemical Industries Co. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Caleco Pharma Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Caleco Pharma Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Caliper Life Sciences, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Caliper Life Sciences, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Callisto Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Callisto Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Calypte Biomedical Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Calypte Biomedical Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Calyx Bio-Ventures Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Calyx Bio-Ventures Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Calzada Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Calzada Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cambrex Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cambrex Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Can-Fite BioPharma Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Can-Fite BioPharma Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

CanBas Co., Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

CanBas Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cangene Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cangene Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cannabis Science, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cannabis Science, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Canopus BioPharma Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Canopus BioPharma Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Caplin Point Laboratories Ltd - Business Profile with Financial and SWOT Analysis

US$ 200.00

Caplin Point Laboratories Ltd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Caps Holdings Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Caps Holdings Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Capsalus Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Capsalus Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Capstone Therapeutics Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Capstone Therapeutics Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Caraco Pharmaceutical Laboratories Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Caraco Pharmaceutical Laboratories Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

CardioGenics Holdings Inc - Business Profile with Financial and SWOT Analysis

US$ 200.00

CardioGenics Holdings Inc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cardiome Pharma Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cardiome Pharma Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

CardioVascular BioTherapeutics, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

CardioVascular BioTherapeutics, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cardium Therapeutics Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cardium Therapeutics Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Carna Biosciences, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Carna Biosciences, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Catalyst Pharmaceutical Partners Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Catalyst Pharmaceutical Partners Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cavit Sciences Inc - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cavit Sciences Inc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

CBio Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

CBio Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

CCM Duopharma Biotech Bhd - Business Profile with Financial and SWOT Analysis

US$ 200.00

CCM Duopharma Biotech Bhd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Ceapro Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Ceapro Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

CEL-SCI Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

CEL-SCI Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Celera Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Celera Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Celestial Biolabs Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Celestial Biolabs Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Celgene Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Celgene Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cell Biotech Co. Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cell Biotech Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cell Kinetics Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cell Kinetics Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cell Tech International Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cell Tech International Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cell Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cell Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cellceutix Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cellceutix Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cellcyte Genetics Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cellcyte Genetics Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Celldex Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Celldex Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Cellectis - Business Profile with Financial and SWOT Analysis

US$ 200.00

Cellectis - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

September 2024 30 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers